{"id":24,"date":"2015-02-02T18:50:25","date_gmt":"2015-02-02T18:50:25","guid":{"rendered":"http:\/\/bio.sites.mtu.edu\/tumban\/?page_id=24"},"modified":"2016-10-04T17:17:06","modified_gmt":"2016-10-04T21:17:06","slug":"conference-presentations","status":"publish","type":"page","link":"https:\/\/bio.sites.mtu.edu\/tumban\/conference-presentations","title":{"rendered":"Conference Presentations"},"content":{"rendered":"

SEMINARS<\/strong><\/p>\n

34th<\/sup> Annual Conference of the American Society for Virology at the University of Western Ontario, London, Ontario, Canada (2015). Title: Immunogenicity of a Newly Formulated Bacteriophage L2 Virus-like Particle-based Vaccine against HPV<\/em><\/p>\n

University of Minnesota Medical School, Duluth, Minnesota\u00a0 (2015). Title: Insights on Bacteriophage L2 Virus-Like Particles Candidate HPV Vaccine: Generation and Formulation<\/em><\/p>\n

Guest speaker on World AIDS Day Symposium at Michigan Technological University (MTU). Event was organized\/sponsored by the following MTU groups: African Student Organization (ASO), Women\u2019s Leadership Council (WLC), National Society of Black Engineers (NSBE), Medlife, Pre-Health Association.<\/p>\n

Sexually Transmitted Infections Cooperative Research Centers annual meeting in Taos, New Mexico (2013). Title: Immunization with bacteriophage L2 VLPs in the presence or absence of endogenous adjuvants has minor effect on immunogenicity of L2.<\/em><\/p>\n

28th<\/sup> International Papillomavirus Conference and Clinical Workshop in San Juan, Puerto Rico (2012). Title: Immunization with L2 bacteriophage VLPs induces long-lasting and broadly protective antibody responses to multiple HPV types.<\/em><\/p>\n

31st<\/sup> Annual Conference of the American Society for Virology\u00a0 at the University of Wisconsin in Madison, Wisconsin (2012). Title: Bacteriophage VLP-based vaccines targeting the minor capsid protein of human papillomavirus induce long-lasting and broadly protective antibody responses.<\/em><\/p>\n

 <\/p>\n

PRESENTED ABSTRACTS<\/strong><\/p>\n

Basu <\/a>R.<\/a>,\u00a0 Workman <\/a>J.<\/a>, and\u00a0 Tumban<\/a>E<\/a>. 2016. Development of Reagents for Human Papillomavirus Therapeutic Vaccines-related Research. 35th<\/sup> Annual Conference of the American Society for Virology at <\/a>Virginia Tech,<\/em> Blacksburg, Virginia. Presentation number P8-1<\/a>.<\/span><\/p>\n

\u00a0Zhai <\/a>L.<\/a>,\u00a0 Stafford <\/a>D.<\/a>, and Tumban<\/a> E. <\/a>2016. Immunization with MS2 Bacteriophage VLPs Displaying Multiple HPVL2 Epitopes Elicits Immune Responses to multiple HPV Epitopes. 35th<\/sup> Annual Conference of the American Society for Virology at <\/a>Virginia Tech,<\/em> Blacksburg, Virginia. Presentation number P8-16<\/a>.<\/span><\/p>\n

Workman J., Basu R., and Tumban E. Spring 2016. Development of Reagents for Chikungunya Virus Vaccine-related Research. Undergraduate Research Expo at Michigan Technological University<\/p>\n

Basu R., Workman J., and Tumban E. Fall 2015. Insertion of HPV16 E7 T Cell Epitope 10-21 into the Coat Protein of Bacteriophage PP7 does not affect the Assembly of the Coat Protein into Virus-like Particles. MI-ASM meeting at the University of Michigan<\/p>\n

Zhai L., Stafford D., and Tumban E. Fall 2015. A Bivalent Epitope L2 MS2 Bacteriophage VLP to Enhance Antibody Responses against HPV L2 Capsid Protein. MI-ASM meeting at the University of Michigan<\/p>\n

Seitz H., Tumban E., Piszczek G., Pang S., Peabody J., Chackerian B., and Schiller J. 2015. Neutralizing antibody responses to HPV L2 by heterologous prime-boost vaccination with mon- and multimeric antigens. 30th<\/sup> International Papillomavirus Conference and Clinical Workshop. Lisbon, Portugal.<\/p>\n

Tyler, E. Tumban, J. Peabody, and B. Chackerian. 2012. Hybrid Virus-like particles displaying multiple L2 epitopes. 28th<\/sup> International Papillomavirus Conference and Clinical Workshop, San Juan, Puerto Rico. Presentation Number BP-135<\/p>\n

Tyler, E. Tumban and B. Chackerian. 2012. Multi-epitope display on virus-like particles. The American Association of Immunologists, Inc, Boston, Massachusetts. Presentation Number 113.26<\/p>\n

Tumban, J. Peabody, D. S. Peabody, and B. Chackerian. 2011. A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2. American Society for Virology. University of Minnesota. Presentation number P21-1.<\/p>\n

Tumban, J. Peabody, D. S. Peabody, and B. Chackerian. 2011. A Phage VLP-based Pan-HPV vaccine targeting the minor capsid protein. 27th<\/sup> International Papillomavirus Conference and Clinical Workshop, Berlin, Germany. Presentation Number O-27.04<\/p>\n

Tyler, E. Tumban, and B. Chackerian. 2011. Mapping HPV L2 epitopes with VLP-based vaccines. 27th<\/sup> International Papillomavirus Conference and Clinical Workshop, Berlin, Germany. Presentation Number O-27.05<\/p>\n

Tumban, J. Painta, and W. Lott. 2005. Comparison of Iron Responsive Element (IRE) and the Hepatitis C Virus (HCV) Internal Ribosome Entry Site (IRES)-Domain IV: Structure and Function. American Society of Tropical Medicine and Hygiene, Washington DC. Presentation Number267<\/p>\n

Tumban, R, Richin, and M. Shaw. 2003. Gene expression in Catharanthus roseus<\/em> infected with Vinca virescence<\/em> phytoplasma. American Phytopathological Society, Charlotte, North Carolina. Phytopathology 93:S84. Publication Number P-2003-0618-AMA<\/p>\n

Tumban, J. Rascoe, and M. Shaw. 2002. Phytoplasma typing based on PCR of 16S rDNA and genetic sequences. American Phytopathological Society, Milwaukee, Wisconsin. Phytopathology 92:S82. Publication Number P-2002-0594-AMA<\/p>\n","protected":false},"excerpt":{"rendered":"

SEMINARS 34th Annual Conference of the American Society for Virology at the University of Western Ontario, London, Ontario, Canada (2015). Title: Immunogenicity of a Newly Formulated Bacteriophage L2 Virus-like Particle-based Vaccine against HPV University of Minnesota Medical School, Duluth, Minnesota\u00a0 (2015). Title: Insights on Bacteriophage L2 Virus-Like Particles Candidate HPV Vaccine: Generation and Formulation Guest […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-24","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/bio.sites.mtu.edu\/tumban\/wp-json\/wp\/v2\/pages\/24","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bio.sites.mtu.edu\/tumban\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bio.sites.mtu.edu\/tumban\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bio.sites.mtu.edu\/tumban\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/bio.sites.mtu.edu\/tumban\/wp-json\/wp\/v2\/comments?post=24"}],"version-history":[{"count":16,"href":"https:\/\/bio.sites.mtu.edu\/tumban\/wp-json\/wp\/v2\/pages\/24\/revisions"}],"predecessor-version":[{"id":259,"href":"https:\/\/bio.sites.mtu.edu\/tumban\/wp-json\/wp\/v2\/pages\/24\/revisions\/259"}],"wp:attachment":[{"href":"https:\/\/bio.sites.mtu.edu\/tumban\/wp-json\/wp\/v2\/media?parent=24"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}